Sponsor
  • ·
  • Chinese Association of
    Integrative Medicine;
    China Academy of Chinese
    Medicine Sciences
Editing
  • ·
  • Editorial Board of
    China Journal of
    Orthopaedics and Traumatology
Publishing
  • ·
  • Publishing House,
    China Journal of
    Orthopaedics and Traumatology
Overseas Distributor
  • ·
  • China International Book
    Trading Corporation
    P.O.Box 399,Beijing,China
    Code No.M587
Mail-order
  • ·
  • Publishing House,
    China Journal of
    Orthopaedics and Traumatology
    No.16A, Nanxiaojie, Dongzhimennei,
    Beijing 100700,China
    Tel:0086-10-84020925
    Fax:0086-10-84036581
    Http://www.zggszz.com
    E-mail:zggszz@sina.com
肺原性心脏病患者骨代谢的改变
Hits: 1761   Download times: 1052   Received:September 15, 2001    
作者Author单位UnitE-Mail
白孟海 BAI Menghai 兰州军区兰州总医院创伤外科研究所,甘肃兰州730050 Instinlte of Orthopaedics,General Hospital of PLA GanSu LanZhou 730050  
葛宝丰 GE Baofeng 兰州军区兰州总医院创伤外科研究所,甘肃兰州730050 Instinlte of Orthopaedics,General Hospital of PLA GanSu LanZhou 730050  
郭永忠 GUO Yongzhong 兰州军区兰州总医院创伤外科研究所,甘肃兰州730050 Instinlte of Orthopaedics,General Hospital of PLA GanSu LanZhou 730050  
高梅 兰州军区兰州总医院创伤外科研究所,甘肃兰州730050 Instinlte of Orthopaedics,General Hospital of PLA GanSu LanZhou 730050  
陈克明 兰州军区兰州总医院创伤外科研究所,甘肃兰州730050 Instinlte of Orthopaedics,General Hospital of PLA GanSu LanZhou 730050  
王琦 兰州军区兰州总医院创伤外科研究所,甘肃兰州730050 Instinlte of Orthopaedics,General Hospital of PLA GanSu LanZhou 730050  
刘剑梅 兰州军区兰州总医院创伤外科研究所,甘肃兰州730050 Instinlte of Orthopaedics,General Hospital of PLA GanSu LanZhou 730050  
期刊信息:《中国骨伤》2003年16卷,第2期,第65-66页
DOI:doi:10.3969/j.issn.1003-0034.yyyy.nn.zzz
目的 通过对肺原性心脏病患者尿脱氧吡啶酚的测定了解骨代谢情况。方法 采用酶联免疫法测定了23例肺心病(男13例,女10例)患者的尿脱氧吡啶酚浓度与23例正常人进行比较。结果 肺原性心脏病患者与对照组的尿脱氧吡啶酚排泄率分别为:男:95.82±36.11,66.80±21.97(t=2417);女:103.99±34.47,65.79±21.98(t=3.037)。肺心病患者的尿脱氧吡啶酚排泄率与对照组比较差异有显著性(P<005)。结论 肺原性心脏病患者,由于长期慢性缺氧等因素,致尿脱氧吡啶酚水平明显增高。提示该组患者骨吸收增加.
[关键词]:肺心病  酶联免疫吸附测定  骨代谢
 
Variations of bone metabolism in patients with pulmonary heart disease
Abstract:

Objective:To study diagnostic value of urine deoxypyridinoline for the detection of bone metabolism in cases of pulmonary heart disease

Methods:Urine deoxypyridinoline was assayed by ELISA in 23 patients of pulmonary heart disease (males 13,females 10) and 23 normal persons served as control.

Results:The urine deoxypyridinoline of males was 95.82±36.11 and of control group 66.80±21.97 (t=2.417).In the females,it was 103.99±34.47 and 65.79±21.98(t=3.307) respectively.All the data had significant difference with the Results of control group.

Conclusion:The urine deoxypyridinoline of patients with pulmonary heart disease was higher because of the long period of chronic lack of oxygen indicating an increased rate of bone absorption.
KEYWORDS:Pulmonary heart disease  ELISA  Bone metabolism
 
引用本文,请按以下格式著录参考文献:
中文格式:白孟海,葛宝丰,郭永忠,高梅,陈克明,王琦,刘剑梅.肺原性心脏病患者骨代谢的改变[J].中国骨伤,2003,16(2):65~66
英文格式:BAI Menghai,GE Baofeng,GUO Yongzhong.Variations of bone metabolism in patients with pulmonary heart disease[J].zhongguo gu shang / China J Orthop Trauma ,2003,16(2):65~66
View Full Text  View/Add Comment  Download reader
Close




版权所有:Editorial Office of China Journal of Orthopaedics and Traumatology京ICP备12048066号  版权声明
地址:No.16A, Nanxiaojie, Dongzhimennei, Beijing 100700, China
电话:0086-10-84036581 传真:0086-10-84036581 Email:zggszz@sina.com